Generic
Linagliptin 5mg + Metformin Hydrochloride 1000mg

Description
Lijenta-MX 5 is a combination of Linagliptin and Metformin Hydrochloride. It is designed to help control blood sugar levels in adults with type 2 diabetes mellitus. This combination targets glucose production and insulin sensitivity to provide better glycemic control.

Benefits
Lijenta-MX 5 helps improve glycemic control, reduces the risk of diabetes complications, and can be used with other antidiabetic medications. It enhances insulin production while decreasing glucose absorption in the liver.

Ingredients
Linagliptin 5mg
Metformin Hydrochloride 1000mg

Uses and Doses
This tablet is used to manage type 2 diabetes mellitus, improving blood sugar levels with diet and exercise. The recommended dose is 2.5mg Linagliptin with 1000mg Metformin twice daily. For patients on Metformin, dosage depends on their existing regimen.

Side Effects
Common side effects include diarrhea, nausea, vomiting, headaches, nasal congestion, sore throat, and respiratory infections. There is also a risk of hypoglycemia, especially when combined with insulin or sulfonylureas.

How to Use
Take Lijenta-MX 5 with food to reduce gastrointestinal side effects. Swallow the tablet whole without chewing, crushing, or breaking it.

Pregnancy & Lactation
There are no well-controlled studies of Lijenta-MX 5 in pregnant or breastfeeding women. Use this medication only if necessary and under medical supervision.

Precautions and Warnings
Patients with renal impairment, lactic acidosis, or those undergoing surgery requiring restricted food intake should avoid this medicine. Regular monitoring of blood sugar and kidney function is advised. Be cautious of potential pancreatitis and discontinue use if it is suspected.

Safety Information
This medication may cause lactic acidosis in people with kidney issues. It is contraindicated for patients with severe renal impairment or metabolic acidosis. Monitor vitamin B12 levels, as Metformin may lower them over time.

Indications
Lijenta-MX 5 is indicated for the management of type 2 diabetes mellitus in adults when both Linaghliptin and Metformin are necessary to achieve glycemic control.

Pharmacology
Linagliptin inhibits the DPP-4 enzyme, increasing insulin release and decreasing glucagon secretion. Metformin reduces glucose production in the liver and increases insulin sensitivity in peripheral tissues, leading to better glucose regulation.

Therapeutic Class
Combination of Oral Hypoglycemic Agents

Storage Conditions
Store in a cool, dry place below 30°C, away from light and moisture. Keep out of reach of children.

3 FAQ

1. Can I take Lijenta-MX 5 without food?
   No, taking this medication with food is recommended to avoid gastrointestinal discomfort.
2. What should I do if I miss a dose?
   Take the missed dose as soon as you remember, but skip it if your next scheduled dose is near.
3. Is Lijenta-MX 5 safe during pregnancy?
   Consult your doctor before using Lijenta-MX 5 during pregnancy, as its safety in pregnant women is not well established.

Disclaimer
This information is intended for general knowledge and should not replace the advice of a healthcare provider. Always consult your doctor or pharmacist for more information about your medication.

Keywords: Linagliptin, metformin hydrochloride, type 2 diabetes, oral hypoglycemic, diabetes treatment, blood sugar control, glycemic control, antidiabetic, extended-release tablets, biguanide, DPP-4 inhibitor, insulin sensitivity, diabetic medication, diabetes mellitus, pancreas, glucose absorption, incretin hormones, hepatic glucose production, lactic acidosis, kidney function, metformin.